FRINX
Price
$11.97
Change
-$0.13 (-1.07%)
Updated
Dec 18 closing price
VGSLX
Price
$126.49
Change
-$5.38 (-4.08%)
Updated
Dec 18 closing price
Ad is loading...

FRINX vs VGSLX

Header iconFRINX vs VGSLX Comparison
Open Charts FRINX vs VGSLXBanner chart's image
Fidelity Advisor Real Estate Income A
Price$11.97
Change-$0.13 (-1.07%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Admiral
Price$126.49
Change-$5.38 (-4.08%)
VolumeN/A
CapitalizationN/A
FRINX vs VGSLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRINX vs. VGSLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRINX is a StrongSell and VGSLX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSLX has more cash in the bank: 70.8B vs. FRINX (5B). FRINX pays higher dividends than VGSLX: FRINX (4.72) vs VGSLX (3.99). FRINX was incepted earlier than VGSLX: FRINX (15 years) vs VGSLX (23 years). FRINX is a more actively managed with annual turnover of: 17.00 vs. VGSLX (9.00). FRINX has a lower initial minimum investment than VGSLX: FRINX (0) vs VGSLX (3000). FRINX annual gain was more profitable for investors over the last year : 9.70 vs. VGSLX (4.85). VGSLX (16.25) and FRINX (15.89) have equivalent 5 years return.
FRINXVGSLXFRINX / VGSLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD8.5564.069210%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5B70.8B7%
Annual Yield % from dividends4.723.99118%
Returns for 1 year9.704.85200%
Returns for 3 years0.64-10.17-6%
Returns for 5 years15.8916.2598%
Returns for 10 years51.9352.5899%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLTR69.27-0.84
-1.20%
Dollar Tree
DORM129.89-4.34
-3.23%
Dorman Products
SSP1.96-0.07
-3.45%
EW Scripps Company (The)
YALA4.21-0.22
-4.97%
Yalla Group Limited
CLRB0.25-0.01
-5.11%
Cellectar Biosciences